Jou J, Zimmer Z, Charo L, Yau C, et al. HIPEC after neoadjuvant chemotherapy and interval debulking is associated with development of platinum-refractory or -resistant disease. Gynecol Oncol 2021;161:25-33.
PMID: 33293046